This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03944/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB03944/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03944/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03944/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/resource/drugbank/drug/DB03944/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03944
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB03944 n11:DB03944
dcterms:title
5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One
adms:identifier
n6:46508463 n7:EMD n8:446286 n13:393684 n14:DB03944
n3:IUPAC-Name
n4:271B522E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5234-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5233-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5230-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5231-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5232-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B522C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B522A-363D-11E5-9242-09173F13E4C5 n4:271B522D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B522B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B523A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B523B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5235-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5236-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5238-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5237-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5239-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5240-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5242-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5243-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B523F-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B523E-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5241-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B522F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B523C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B523D-363D-11E5-9242-09173F13E4C5